FilingIndex
10-KThe Record

Kalaris Therapeutics, Inc. files 10-K

Filed Feb 10, 2022 · 4y ago · Accession 0000950170-22-001075

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
KLRS
CIK
1754068
Form type
10-K
Filing date
Feb 10, 2022
Report date
Dec 31, 2021
Document
alvr-20211231.htm
Size
18.7 MB